Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis.

Authors: Krakow, D  Robertson, SP  King, LM  Morgan, T  Sebald, ET  Bertolotto, C  Wachsmann-Hogiu, S  Acuna, D  Shapiro, SS  Takafuta, T  Aftimos, S  Kim, CA  Firth, H  Steiner, CE  Cormier-Daire, V  Superti-Furga, A  Bonafe, L  Graham JM, JR  Grix, A  Bacino, CA  Allanson, J  Bialer, MG  Lachman, RS  Rimoin, DL  Cohn, DH 
Citation: Krakow D, etal., Nat Genet. 2004 Apr;36(4):405-10. Epub 2004 Feb 29.
Pubmed: (View Article at PubMed) PMID:14991055
DOI: Full-text: DOI:10.1038/ng1319

The filamins are cytoplasmic proteins that regulate the structure and activity of the cytoskeleton by cross-linking actin into three-dimensional networks, linking the cell membrane to the cytoskeleton and serving as scaffolds on which intracellular signaling and protein trafficking pathways are organized (reviewed in refs. 1,2). We identified mutations in the gene encoding filamin B in four human skeletal disorders. We found homozygosity or compound heterozygosity with respect to stop-codon mutations in autosomal recessive spondylocarpotarsal syndrome (SCT, OMIM 272460) and missense mutations in individuals with autosomal dominant Larsen syndrome (OMIM 150250) and the perinatal lethal atelosteogenesis I and III phenotypes (AOI, OMIM 108720; AOIII, OMIM 108721). We found that filamin B is expressed in human growth plate chondrocytes and in the developing vertebral bodies in the mouse. These data indicate an unexpected role in vertebral segmentation, joint formation and endochondral ossification for this ubiquitously expressed cytoskeletal protein.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 1601168
Created: 2007-04-10
Species: All species
Last Modified: 2007-04-10
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.